Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.190
+0.060 (1.92%)
Dec 20, 2024, 4:00 PM EST - Market closed
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $269.44 million as of December 20, 2024. Its market cap has increased by 9.84% in one year.
Market Cap
269.44M
Enterprise Value
-211.54M
1-Year Change
9.84%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $269.44M, a decrease of -86.10%. That is a compound annual growth rate of -37.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 269.44M | 5.88% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | 3.45B | 78.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accolade | 267.38M |
| ProQR Therapeutics | 267.30M |
| 4D Molecular Therapeutics | 267.20M |
| AC Immune | 267.14M |
| aTyr Pharma | 264.42M |
| iTeos Therapeutics | 263.77M |
| Bright Minds Biosciences | 263.33M |
| Senseonics Holdings | 263.13M |